FDA Restricts Johnson & Johnson Covid-19 Shot Due to Risk of Blood Clots

FDA Restricts Johnson & Johnson Covid-19 Shot Due to Risk of Blood Clots

FDA Restricts Johnson & Johnson Covid-19 Shot Due to Risk of Blood Clots…


The U.S. Food and Drug Administration announced on Thursday that it would limit who can receive the Johnson & Johnson/Janssen Covid-19 shot due to the serious risk of blood clots.

The FDA announced that it would limit the authorized use of J&J Covid-19 shot to individuals 18 years of age and older for whom other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, and to individuals 18 years of age and older who elect to receive the Janssen COVID-19 Vaccine because they would otherwise not receive a COVID-19 vaccine.